| JXSS2500061 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.1) | Import Drug Application | 2025-05-14 | | Johnson & Johnson;Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2500075 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2500022 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2025-02-07 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2500003 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2500002 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2400635 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-09-21 | | CSPC Megalith Biopharmaceutical Co Ltd | | | view |
| JYSB2400095 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2024-04-25 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2400094 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2024-04-25 | | Cilag AG;Janssen-Cilag AG | | | view |
| CXSL2400135 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-02-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2400136 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.3) | New Drug Application | 2024-02-21 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| JYSB2300204 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-12-08 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSZ2300047 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag AG | | | view |
| JYSZ2300046 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300140 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-08-18 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2300079 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300078 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300077 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300076 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JXSL2300072 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products(3.4) | Import Drug Application | 2023-04-21 | | Janssen-Cilag AG;Johnson & Johnson (CHINA) Investment Ltd | | | view |
| JXSB2300033 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products(3.4) | Supplementary Application | 2023-03-28 | | Cilag AG;Janssen Research & Development LLC | | | view |
